Philadelphia Pharmaceuticals Co. Upgraded to 'Hold' Amid Mixed Technical Indicators
Philadelphia Pharmaceuticals Co. has transitioned from a 'Not Rated' status to a 'Hold' designation by MarketsMojo, reflecting a revised evaluation of its valuation and technical metrics. The company maintains a fair valuation and has shown stable financial performance, despite underperforming the broader market over the past year.
Philadelphia Pharmaceuticals Co., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, moving from a 'Not Rated' status to a 'Hold' designation by MarketsMOJO. This revision reflects a nuanced assessment of the company's valuation and technical metrics.The technical indicators present a mixed picture. The MACD shows a bullish trend on a weekly basis, while the monthly perspective remains mildly bearish. The Relative Strength Index (RSI) indicates bearish conditions weekly, with no signal on a monthly basis. Additionally, Bollinger Bands suggest a mildly bullish outlook weekly and a bullish stance monthly. The moving averages indicate a mildly bullish trend, while the KST presents a bullish weekly view but a mildly bearish monthly outlook.
In terms of valuation, Philadelphia Pharmaceuticals Co. has been classified as having a fair valuation, with key metrics such as an EV to EBIT ratio of 0.63 and an EV to EBITDA ratio of 0.50. The company reported a return on capital employed (ROCE) of 10.62% and a return on equity (ROE) of 7.02%, indicating a stable financial position.
Despite a positive financial performance in the quarter ending June 2025, the stock has underperformed the broader market, generating a return of 4.23% over the past year compared to the Jordan General Index's 28.95%.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Most Read
